“…Research suggests that myostatin stimulates expression of RGS2 preventing cardiac hypertrophy and heart failure [35]. The role of RGS2 in cardiovascular system inflammation and in cancer [36][37][38] is still under observation and can be an interesting link to cardio-oncology while new findings are emerging with regard to the use of cardiovascular drugs [55,68,69,73,74,84]. In primary human airway smooth muscle cells, glucocorticoid/ long-acting β (2)-adrenoceptor agonist (LABA) combination synergistically induces the expression of RGS2 reduced intracellular free calcium flux elicited by histamine, methacholine, leukotrienes, and other spasmogens [37].…”